Commerzbank Cuts 30.5% AbbVie Stake; Q4 EPS Guidance Raised to $3.32–$3.36
Commerzbank cut its AbbVie stake by 30.5% to 90,102 shares worth $20.9 million, while First Citizens trimmed its position by 6.5% to 34,834 shares valued at $8.07 million. Morgan Stanley lifted its AbbVie target price to $269 and the company set Q4 EPS guidance at $3.32–$3.36 alongside a dividend increase to $1.73 per share.
Related News
NVDL
GraniteShares 2x Daily Nvidia ETF Gains 172%, Tops $4 Billion AUM
NVDL•
TOST
Toast Sponsors ICC UK Initiative, Showcases Platform Powering 171,000 Global Locations
TOST•
GS
Goldman Sachs to Lead $1.75 Trillion SpaceX IPO With $1.45B Bitcoin Disclosure
GS•
MSFT
Microsoft’s AI Spending Drives 50% of Nvidia’s $38 B Data Center Revenue
MSFT•
TJX
TJX Beats Q1 EPS by $0.20, Comps Up 6% and Spain Store Launch
TJX•
Sources
SDD